Glenmark Pharma, an India-based drug manufacturer that has been the focal point of a spate of recalls in recent years, has issued another. This time, the product pull covers about 1.48 million ...

In a regulatory filing, the Mumbai-based drug maker said that in 2023 it had settled with three plaintiff groups referred as the Direct Purchaser Plaintiffs, the Retailer Plaintiffs, and the End-Payor ...

Glenmark Pharmaceuticals Inc., USA announced today the acquisition and launch of Acetylcysteine Injection, 6 gm/30 mL (200 mg/mL) Single-Dose Vials in the US market. The shares of Glenmark ...

Glenmark Pharmaceuticals is recalling close to 15 lakh bottles of a generic medication used in the treatment of attention deficit hyperactivity disorder in the U.S. market, according to the U.S ...